Newt Crenshaw on Assessing the Value of Cancer Treatments
Newt Crenshaw, Vice President of Oncology at Lilly, explains the importance of coming together and having a conversation about the issues associated with value, from ensuring patient access to scientific advances to the way that new medicines benefit our society as a whole.